Key points are not available for this paper at this time.
A series of highly thermally stable lanthanide metal–organic frameworks formulated as Ln2 (TATB) 2 (DMSO) 6·DMF·DMSO·H2O Ln = La (1), Ce (2), Pr (3), Sm (4), Eu (5) and Ln2 (TATB) 2 (DMSO) 5 (CH3OH) ·DMF·DMSO·2H2O Ln = Nd (6), Gd (7), Tb (8) (TATB3− = 4, 4′, 4′′-s-triazine-2, 4, 6-triyl-tribenzoate, DMF = N, N-dimethylformamide and DMSO = dimethylsulfoxide) have been successfully synthesized under solvothermal conditions and characterized by single crystal X-ray diffraction, infrared (IR) spectroscopy, elemental analysis, thermogravimetric analyses (TGA) and powder X-ray diffraction (PXRD). Single crystal X-ray diffraction analysis reveals that all of the compounds are isomorphous, crystallize in the triclinic space group 1 and exhibit two-dimensional (2D) (3, 3) -connected layered structures with the Schläfli symbol 63. Solid-state photoluminescence measurement illustrates that compounds 5 and 8 exhibit remarkable red and green luminescence emissions with lifetimes at the millisecond scale, respectively, while complexes 3, 4, and 6 display characteristic luminescence emissions in the near-infrared region. With careful adjustment of the relative concentration of the doping Eu3+ and Tb3+ ions in the La3+ complex, the color of the luminescence can be modulated, and white-light emitting materials can be successfully obtained.
Rong et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: